Takeshi Yoshida Selected Research

Takeshi Yoshida Research Topics

Disease

35	Neoplasms (Cancer) 01/2022 - 07/2003
15	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 05/2006
14	Lung Injury 01/2022 - 05/2012
11	Choroidal Neovascularization 07/2019 - 04/2003
10	Myopia 05/2022 - 04/2004
10	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 06/2008
9	Infections 01/2022 - 02/2002
8	Macular Degeneration (Age-Related Maculopathy) 05/2022 - 10/2005
7	Lung Neoplasms (Lung Cancer) 09/2021 - 06/2002
7	Atrophy 10/2020 - 04/2004
6	Disease Progression 09/2021 - 10/2011
5	Atopic Dermatitis (Atopic Eczema) 12/2019 - 03/2011
4	Ischemic Stroke 05/2022 - 01/2020
4	Inflammation (Inflammations) 09/2021 - 07/2008
4	Septic Shock (Toxic Shock Syndrome) 08/2021 - 01/2018
4	Sepsis (Septicemia) 08/2021 - 01/2018
4	Retinoschisis (Retinoschisis, Juvenile) 01/2021 - 04/2010
4	Aortic Dissection 01/2020 - 01/2018
4	Neoplasm Metastasis (Metastasis) 01/2017 - 06/2002
4	Stomach Neoplasms (Stomach Cancer) 12/2016 - 02/2009
4	Brain Diseases (Brain Disorder) 12/2014 - 04/2007
3	Rheumatoid Arthritis 07/2022 - 09/2006
3	Critical Illness (Critically Ill) 06/2022 - 10/2021
3	Hypoxia (Hypoxemia) 12/2020 - 06/2008
3	Hemorrhage 09/2020 - 07/2015
3	Human Influenza (Influenza) 01/2020 - 12/2018
3	Glycogen Storage Disease Type II (Pompe's Disease) 01/2019 - 10/2017
3	Pain (Aches) 01/2018 - 02/2011
3	Ventilator-Induced Lung Injury 01/2018 - 01/2016
2	Osteomyelitis 07/2022 - 12/2013
2	Arthritis (Polyarthritis) 07/2022 - 08/2021
2	COVID-19 06/2022 - 12/2020
2	Stroke (Strokes) 01/2022 - 02/2009
2	Fistula 10/2021 - 01/2019
2	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2021 - 01/2012
2	Infantile Spasms (West Syndrome) 06/2021 - 04/2016
2	Drug Resistant Epilepsy 06/2021 - 09/2015
2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2016
2	Edema (Dropsy) 01/2021 - 10/2008
2	Cysts 01/2021 - 04/2008
2	Patient-Ventilator Asynchrony 12/2020 - 09/2016

Drug/Important Bio-Agent (IBA)

13	Tyrosine Kinase InhibitorsIBA 09/2021 - 03/2007
13	ErbB Receptors (EGF Receptor)IBA 01/2019 - 03/2007
12	Retinaldehyde (Retinal)IBA 05/2022 - 04/2004
7	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2011
7	LigandsIBA 01/2021 - 01/2015
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
6	AntibodiesIBA 01/2020 - 02/2002
6	Gefitinib (Iressa)FDA Link 03/2016 - 03/2007
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2012 - 06/2002
5	Surface-Active Agents (Surfactants)IBA 01/2022 - 02/2013
5	Dasatinib (BMS 354825)FDA Link 01/2019 - 01/2010
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2016 - 03/2007
4	Fluorescein (Funduscein)FDA LinkGeneric 08/2021 - 02/2002
4	Cetuximab (Erbitux)FDA Link 01/2021 - 04/2008
4	AntigensIBA 01/2020 - 11/2008
4	Indicators and Reagents (Reagents)IBA 01/2020 - 06/2002
4	AfatinibIBA 01/2019 - 08/2014
4	Messenger RNA (mRNA)IBA 11/2017 - 05/2006
4	Bevacizumab (Avastin)FDA Link 06/2017 - 05/2009
4	Phosphotransferases (Kinase)IBA 01/2016 - 05/2010
4	Amyloid beta-PeptidesIBA 07/2011 - 10/2005
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2011 - 03/2008
4	Cisplatin (Platino)FDA LinkGeneric 02/2009 - 01/2005
3	Pharmaceutical PreparationsIBA 01/2022 - 12/2013
3	SteroidsIBA 09/2021 - 12/2013
3	Biological ProductsIBA 04/2021 - 12/2003
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 12/2018
3	GlycogenIBA 01/2019 - 04/2008
3	AcidsIBA 01/2019 - 10/2008
3	Neuregulin-1 (Neuregulin 1)IBA 12/2016 - 01/2015
3	Anti-Bacterial Agents (Antibiotics)IBA 03/2010 - 09/2005
2	AlbuminsIBA 01/2022 - 09/2021
2	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2021 - 04/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 12/2014
2	Formaldehyde (Formol)FDA Link 01/2021 - 01/2019
2	ParaffinIBA 01/2021 - 01/2019
2	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020 - 01/2011
2	Neuromuscular Blocking AgentsIBA 12/2020 - 02/2013

Therapy/Procedure

25	Therapeutics 07/2022 - 09/2005
16	Artificial Respiration (Mechanical Ventilation) 06/2022 - 05/2012
8	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 01/2016
5	Lasers (Laser) 08/2021 - 04/2004
5	Drug Therapy (Chemotherapy) 01/2021 - 12/2003
4	Immunotherapy 07/2022 - 05/2006
4	Critical Care (Surgical Intensive Care) 08/2021 - 01/2018
4	Photochemotherapy (Photodynamic Therapy) 01/2011 - 03/2008
3	Debridement 07/2022 - 03/2010
3	Traction 05/2022 - 04/2008
3	Combination Drug Therapy (Combination Chemotherapy) 01/2021 - 03/2008
3	Radiotherapy 01/2021 - 03/2016
3	Intravitreal Injections 01/2020 - 05/2009
3	Endovascular Aneurysm Repair 07/2019 - 12/2015
2	Tracheostomy 06/2022 - 04/2022
2	Stents 10/2021 - 07/2019
2	Injections 06/2021 - 07/2019
2	Denervation 01/2021 - 09/2015
2	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2014